(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial

BACKGROUND: (1,3)-β-d-Glucan has been widely used in clinical practice for the diagnosis of invasive Candida infections. However, such serum biomarker showed potential to guide antimicrobial therapy in order to reduce the duration of empirical antifungal treatment in critically ill septic patients w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Crit Care
Asıl Yazarlar: De Pascale, Gennaro, Posteraro, Brunella, D’Arrigo, Sonia, Spinazzola, Giorgia, Gaspari, Rita, Bello, Giuseppe, Montini, Luca Maria, Cutuli, Salvatore Lucio, Grieco, Domenico Luca, Di Gravio, Valentina, De Angelis, Giulia, Torelli, Riccardo, De Carolis, Elena, Tumbarello, Mario, Sanguinetti, Maurizio, Antonelli, Massimo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487510/
https://ncbi.nlm.nih.gov/pubmed/32891170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03265-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller